HRP20181756T1 - Režim liječenja sa spojem tiakumicina - Google Patents

Režim liječenja sa spojem tiakumicina

Info

Publication number
HRP20181756T1
HRP20181756T1 HRP20181756TT HRP20181756T HRP20181756T1 HR P20181756 T1 HRP20181756 T1 HR P20181756T1 HR P20181756T T HRP20181756T T HR P20181756TT HR P20181756 T HRP20181756 T HR P20181756T HR P20181756 T1 HRP20181756 T1 HR P20181756T1
Authority
HR
Croatia
Prior art keywords
treatment regimen
tiacumicin compound
tiacumicin
compound
regimen
Prior art date
Application number
HRP20181756TT
Other languages
English (en)
Inventor
Andreas Johannis KARAS
Christopher Mark LONGSHAW
Original Assignee
Astellas Pharma Europe Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Europe Ltd. filed Critical Astellas Pharma Europe Ltd.
Publication of HRP20181756T1 publication Critical patent/HRP20181756T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
HRP20181756TT 2014-05-09 2018-10-24 Režim liječenja sa spojem tiakumicina HRP20181756T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14075031 2014-05-09
EP15731245.5A EP3139932B1 (en) 2014-05-09 2015-05-11 Treatment regimen for tiacumicin compound
PCT/EP2015/000965 WO2015169451A1 (en) 2014-05-09 2015-05-11 Treatment regimen tiacumicin compound

Publications (1)

Publication Number Publication Date
HRP20181756T1 true HRP20181756T1 (hr) 2018-12-28

Family

ID=50771031

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181756TT HRP20181756T1 (hr) 2014-05-09 2018-10-24 Režim liječenja sa spojem tiakumicina

Country Status (23)

Country Link
US (1) US10137141B2 (hr)
EP (1) EP3139932B1 (hr)
JP (1) JP6579662B2 (hr)
KR (1) KR20160149288A (hr)
AU (1) AU2015258130B2 (hr)
CA (1) CA2948400A1 (hr)
CY (1) CY1120847T1 (hr)
DK (1) DK3139932T3 (hr)
EA (1) EA031756B1 (hr)
ES (1) ES2694028T3 (hr)
GE (1) GEP20186872B (hr)
HR (1) HRP20181756T1 (hr)
IL (1) IL248782B (hr)
LT (1) LT3139932T (hr)
MA (1) MA39952B1 (hr)
MD (1) MD4695C1 (hr)
PL (1) PL3139932T3 (hr)
PT (1) PT3139932T (hr)
RS (1) RS57994B1 (hr)
SI (1) SI3139932T1 (hr)
TR (1) TR201815891T4 (hr)
UA (1) UA122203C2 (hr)
WO (1) WO2015169451A1 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017005358A1 (en) * 2015-07-03 2017-01-12 Astellas Pharma Europe Ltd. Novel dosage regimen tiacumicin compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
WO2006085838A1 (en) 2005-01-31 2006-08-17 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
WO2004014295A2 (en) 2002-07-29 2004-02-19 Optimer Pharmaceuticals, Inc. Tiacumicin production
SI2070530T1 (sl) 2004-05-14 2016-05-31 Merck Sharp & Dohme Corp. Zdravljenje bolezni, povezanih z uporabo antibiotikov
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
US20080176927A1 (en) * 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
CN102030791B (zh) 2010-10-28 2013-01-23 中国科学院南海海洋研究所 四种台勾霉素类化合物及其制备方法和在制备抗菌药物中的应用
CN102115757B (zh) 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
WO2013138748A1 (en) * 2012-03-16 2013-09-19 Optimer Pharmaceuticals, Inc. Prevention of clostridium difficile infection in high risk patients
JO3464B1 (ar) * 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين

Also Published As

Publication number Publication date
TR201815891T4 (tr) 2018-11-21
EP3139932B1 (en) 2018-08-01
EA031756B1 (ru) 2019-02-28
MD4695B1 (ro) 2020-05-31
DK3139932T3 (en) 2018-11-12
IL248782B (en) 2020-08-31
UA122203C2 (uk) 2020-10-12
PL3139932T3 (pl) 2019-02-28
LT3139932T (lt) 2018-11-12
US10137141B2 (en) 2018-11-27
ES2694028T3 (es) 2018-12-17
CY1120847T1 (el) 2019-12-11
CA2948400A1 (en) 2015-11-12
RS57994B1 (sr) 2019-01-31
MD4695C1 (ro) 2021-02-28
MA39952A (fr) 2017-03-15
GEP20186872B (en) 2018-06-25
EP3139932A1 (en) 2017-03-15
WO2015169451A1 (en) 2015-11-12
AU2015258130B2 (en) 2019-10-31
MA39952B1 (fr) 2018-12-31
MD20160131A2 (ro) 2017-05-31
US20170143750A1 (en) 2017-05-25
EA201692107A1 (ru) 2017-04-28
JP6579662B2 (ja) 2019-09-25
PT3139932T (pt) 2018-11-14
KR20160149288A (ko) 2016-12-27
IL248782A0 (en) 2017-01-31
AU2015258130A1 (en) 2016-12-15
JP2017514880A (ja) 2017-06-08
SI3139932T1 (sl) 2018-12-31

Similar Documents

Publication Publication Date Title
AP2017009836A0 (en) Aminopyridyloxypyrazole compounds
GB201415573D0 (en) Compounds
GB201411418D0 (en) Compounds
GB201418300D0 (en) Compounds
GB201410430D0 (en) Compounds
GB201402431D0 (en) Compounds
GB201417369D0 (en) Compounds
GB201417561D0 (en) Compounds
GB201416186D0 (en) Compounds
GB201404987D0 (en) Compounds
GB201406956D0 (en) Compounds
GB201406591D0 (en) Compounds
GB201419228D0 (en) Compounds
AP2017009778A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201419264D0 (en) Compounds
GB201412660D0 (en) Compounds
GB201417168D0 (en) Compounds
GB201419015D0 (en) Compounds
HRP20181756T1 (hr) Režim liječenja sa spojem tiakumicina
GB201407695D0 (en) Compounds
GB201405361D0 (en) Compounds
GB201416462D0 (en) Compound for use
GB201419321D0 (en) Compounds
GB201419322D0 (en) Compounds
GB201418491D0 (en) Compounds